10.1016/j.jlr.2022.100179 195 SeifertL.MillerG
As preventative care has shown little success in halting the rise in cardiometabolic diseases, new medicines will be crucial for improving the quality of life and independence of as many patients as possible
When to talk to your clinician : If youre considering tirzepatide, ask about goals, the expected timeline for results, possible side effects, drug interactions with your current medications, and insurance coverage
Texas Tech University
However, if you experience severe vomiting early in your GLP-1 treatment, use backup contraception for that cycle
This question arises as obesity rates increase among inflammatory bowel disease patients, prompting interest in GLP-1 receptor agonists like semaglutide (Wegovy) and liraglutide (Saxenda)